Comparison of Early Morbidity and Mortality Between Sleeve Gastrectomy and Gastric Bypass in High-Risk Patients for Liver Disease: Analysis of American College of Surgeons National Surgical Quality Improvement Program
- PMID: 29696572
- DOI: 10.1007/s11695-018-3259-z
Comparison of Early Morbidity and Mortality Between Sleeve Gastrectomy and Gastric Bypass in High-Risk Patients for Liver Disease: Analysis of American College of Surgeons National Surgical Quality Improvement Program
Erratum in
-
Correction to: Comparison of Early Morbidity and Mortality Between Sleeve Gastrectomy and Gastric Bypass in High-Risk Patients for Liver Disease: Analysis of American College of Surgeons National Surgical Quality Improvement Program.Obes Surg. 2018 Sep;28(9):2852. doi: 10.1007/s11695-018-3304-y. Obes Surg. 2018. PMID: 29761262
Abstract
Introduction: Chronic liver disease is prevalent in obese patients presenting for bariatric surgery and is associated with increased postoperative morbidity and mortality (M&M). There are no comparative studies on the safety of different types of bariatric operations in this subset of patients.
Objective: The aim of this study is to compare the 30-day postoperative M&M between laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-Y-gastric bypass (LRYGB) in the subset of patients with a model of end-stage liver disease (MELD) score ≥ 8.
Methods: Data for LSG and LRYGB were extracted from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from years 2012 and 2013. MELD score was calculated using serum creatinine, bilirubin, INR, and sodium. Postoperative M&M were assessed in patients with a score ≥ 8 and compared for the type of operation. This was followed by analysis for MELD subcategories. Multiple logistic regression was performed to adjust for confounders.
Results: Out of 34,169, 9.8% of cases had MELD ≥ 8 and were included. Primary endpoint, 30-day M&M, was significantly lower post-LSG (9.5%) compared to LRYGB (14.7%); [AOR = 0.66(0.53, 0.83)]. Superficial wound infection, prolonged hospital stay, and unplanned readmission were more common in LRYGB. M&M post-LRYGB (30.6%) was significantly higher than LSG (15.7%) among MELD15-19 subgroup analysis.
Conclusion: LRYGB is associated with a higher postoperative risk than LSG in patients with MELD ≥ 8. The difference in postoperative complications between procedures was magnified with higher MELD. This suggests that LSG might be a safer option in morbidly obese patients with higher MELD scores, especially above 15.
Keywords: Bariatric surgery; Gastric bypass; Liver disease; MELD score; Sleeve gastrectomy.
Similar articles
-
Laparoscopic Sleeve Gastrectomy Is Associated with Lower 30-Day Morbidity Versus Laparoscopic Gastric Bypass: an Analysis of the American College of Surgeons NSQIP.Obes Surg. 2018 Nov;28(11):3567-3572. doi: 10.1007/s11695-018-3396-4. Obes Surg. 2018. PMID: 30014238
-
Perioperative outcomes of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in super-obese and super-super-obese patients: a national database analysis.Surg Obes Relat Dis. 2019 Oct;15(10):1696-1703. doi: 10.1016/j.soard.2019.07.026. Epub 2019 Aug 10. Surg Obes Relat Dis. 2019. PMID: 31530452
-
Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database.Obes Surg. 2020 Jan;30(1):111-118. doi: 10.1007/s11695-019-04175-x. Obes Surg. 2020. PMID: 31598899 Free PMC article.
-
A Comprehensive Comparison of LRYGB and LSG in Obese Patients Including the Effects on QoL, Comorbidities, Weight Loss, and Complications: a Systematic Review and Meta-Analysis.Obes Surg. 2020 Mar;30(3):819-827. doi: 10.1007/s11695-019-04306-4. Obes Surg. 2020. PMID: 31834563 Free PMC article.
-
Learning Curves of Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Bariatric Surgery: a Systematic Review and Introduction of a Standardization.Obes Surg. 2020 Feb;30(2):640-656. doi: 10.1007/s11695-019-04230-7. Obes Surg. 2020. PMID: 31664653
Cited by
-
European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.United European Gastroenterol J. 2022 Sep;10(7):663-720. doi: 10.1002/ueg2.12280. Epub 2022 Aug 12. United European Gastroenterol J. 2022. PMID: 35959597 Free PMC article. Review.
-
Preoperative MELD score predicts mortality and adverse outcomes following radical cystectomy: analysis of American College of Surgeons National Surgical Quality Improvement Program.Ther Adv Urol. 2022 Nov 15;14:17562872221135944. doi: 10.1177/17562872221135944. eCollection 2022 Jan-Dec. Ther Adv Urol. 2022. PMID: 36407007 Free PMC article.
-
Does Preoperative MELD Score Predict Adverse Outcomes Following Pancreatic Resection: an ACS NSQIP Analysis.J Gastrointest Surg. 2020 Oct;24(10):2259-2268. doi: 10.1007/s11605-019-04380-0. Epub 2019 Aug 29. J Gastrointest Surg. 2020. PMID: 31468333
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical